Cochrane Evidence Synthesis and Methods ►

Proton pump inhibitor versus placebo in the short term management of gastro-esophageal reflux disease

Meta-analysis of randomised controlled trials to assess the efficacy of short term use of proton pump inhibitors (PPIs) against placebo in the management of GORD and GORD-associated symptoms.

This is a protocol.

Health topics:

Gastroenterology & hepatology > Gastro-oesophageal reflux

Published:

31 May 2013

Authors:

Elmazariky N, Neumann I, Armstrong D, Leontiadis GI, Moayyedi P

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Elmazariky N, Neumann I, Armstrong D, Leontiadis GI, Moayyedi P. Proton pump inhibitor versus placebo in the short term management of gastro-esophageal reflux disease. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD010499. DOI: 10.1002/14651858.CD010499